drugset / Trial / NCT05505162
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
NaSingle-groupOpen-labelTreatment
Summary
A study to assess the Pharmacokinetics (PK) of combined oral ethinyl estradiol (EE) and levonorgestrel (LNG) in healthy female participants of non-child-bearing potential, when administered alone and in combination with multiple oral doses of zibotentan.
Timeline
- Start
- 2022-08-24
- Primary completion
- 2023-01-10
- Completion
- 2023-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | — | Oral |
| Subject | Zibotentan | Small molecule | — | Oral |
| Subject | ethinyl estradiol | Small molecule | — | Oral |
Indications
No indication recorded.